Skip to content
Teethgrinder – Lifestyle
Author:
Innogen Pharmaceuticals
Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
May 29, 2026